Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ivim Health vs Roen Rx

Ivim Health
Graded #338

Higher grade

vs+0.3999999999999986
Roen Rx
Graded #348

Lower grade

The verdict

Ivim Health takes it — 59.6/100 to 59.2/100, but only just.

Ivim Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ivim Health is a telehealth weight-loss programme selling compounded semaglutide starting at $149/mo and compounded tirzepatide starting at $224/mo, each quoted with medication and programme charges included. Roen Rx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvim Health +5
44
39
Dose & formulationRoen Rx +13
64
77
Clinical oversightIvim Health +5
79
74
Labs & monitoringRoen Rx +1
52
53
FulfillmentRoen Rx +2
65
67
Contract termsIvim Health +14
55
41
Ivim Health · left barRoen Rx · right bar

The numbers

MetricIvim HealthRoen Rx
WeighScore59.6/10059.2/100
GradeCC
Scorecard rank#338#348
Semaglutide$149/mo (starting dose, medication and programme fee, compounded)$151/mo (3-month plan, plus a separate fee, compounded)
Tirzepatide$224/mo (starting dose, medication and programme fee, compounded)$216/mo (plus a separate fee, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Ivim Health

Graded #338 · C

Strengths

  • Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
  • A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
  • The first month of the membership is free

Where it loses points

  • A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
  • The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
  • Both figures are 'starting at' rates, so the cost of a titrated dose is not published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Roen Rx

Graded #348 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • Both compounded and brand-name options
  • LegitScript approved with Compounded USA badge
  • Compounded semaglutide from $151/mo quarterly
  • Also offers primary care, mental health, and other specialties

Where it loses points

  • State availability not publicly disclosed
  • Insurance coordination may not work for all plans
  • Broader platform (ED, hair loss, skincare, birth control)
  • Requires a separate membership (first month $39); GLP-1 medications are NOT included in the membership fee - medication is billed on top

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard